Toronto [Canada], January 2 (ANI): Effective ways to control the spread of COVID-19 that have been already by the policymakers around the globe have been probed by the researchers from the University of Toronto, Rotman School of Management.
Toronto [Canada], December 30 (ANI): The researchers from the University of Toronto, Rotman School of Management probed about the most effective ways to control the spread of COVID-19 that have been already by the policymakers around the globe.
New York [USA], July 27 (ANI): Chinese authorities have been collecting DNA samples from across the country to develop a massive genetic database, in a bid to create a new tool for their emerging high-tech surveillance state.
Washington D.C. [USA], Feb 4 (ANI): Printing new skin cells on a burn injury may eventually become the new treatment to treat burns, shared a team of researchers from Canada. They have successfully tested the newly developed 'handheld 3D printer'.
Washington D.C. [USA], Dec 8 (ANI): A study has found that the content of brown fat which is present in the human body close to the nervous system can be increased by burning more energy.
Toronto [Canada], Aug 6 (ANI): Did you know your selfie could give an insight into your health? Scientists at the University of Toronto have published a proof-of-concept that a smartphone app could measure blood pressure by analysing a selfie video.
Washington D.C. [USA], Jan 09 (ANI): While the elite have always loved their truffles and caviar, a new study by UBC sociology professor Emily Huddart Kennedy and colleagues from the University of Toronto finds that free-range and fair-trade foods are becoming increasingly important among th
New Delhi [India], July 24 (ANI): Toronto Recombinant Antibody Centre (TRAC) from the University of Toronto, Canada agreed to license MedGenome's patented cancer immunotherapy solution OncoPept to develop biomarkers for their drug candidates against immune modulators to treat cancer.
New Delhi [India], July 22 (ANI): Toronto Recombinant Antibody Centre (TRAC) from the University of Toronto, Canada agreed to license MedGenome's patented cancer immunotherapy solution OncoPept to develop biomarkers for their drug candidates against immune modulators to treat cancer.
New Delhi [India], July 22 (ANI): Toronto Recombinant Antibody Centre (TRAC) from the University of Toronto, Canada agreed to license MedGenome's patented cancer immunotherapy solution OncoPept to develop biomarkers for their drug candidates against immune modulators to treat cancer.